Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

572
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
572
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

847
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
847
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

203
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

758
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
758
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

737
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
737
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interpretable Survival Modeling for Mortality Risk Stratification in Heart Failure Using Cox Proportional Hazard Regression.

Current health sciences journal·2026
Same author

Reliable deep learning for coronary artery disease detection: a patient-level, statistically validated MRI study.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie·2026
Same author

Retroauricular Kimura Disease in a Young European Female: A Rare Case and Review of the Literature.

Life (Basel, Switzerland)·2026
Same author

Immunoprofile of some transmembrane adhesion molecules in oral squamous cell carcinoma.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie·2025
Same author

Higher NLR Values Can Predict Gram-Negative Spontaneous Bacterial Peritonitis and a High In-Hospital Mortality Rate in Patients with Spontaneous Bacterial Peritonitis.

Life (Basel, Switzerland)·2025
Same author

Sweet Syndrome-like Dermatosis as a Precursor to Overlapping Hematologic Malignancies: A Case Report and Review.

Journal of clinical medicine·2025

Related Experiment Video

Updated: Jan 8, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

Leveraging artificial intelligence for cardiovascular risk: a primary care perspective.

Christiana Raluca Dănciulescu1, Mircea Sorin Ciolofan, Constantin Renato Ivănescu

  • 1Department of Otorhinolaryngology, University of Medicine and Pharmacy of Craiova, Romania; sorin.ciolofan@yahoo.com.

Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie
|December 12, 2025
PubMed
Summary

Artificial intelligence (AI) using temporal deep learning models can predict cardiovascular risk (CVR) in primary care. This supports early detection and tailored interventions, improving patient outcomes.

Keywords:
cardiovascular diseasedeep learningfamily practicestatistical analysis

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.2K
Estimate the Cognitive Load Using Electrocardiographic Measure: A Human-AI Collaborative Task
07:08

Estimate the Cognitive Load Using Electrocardiographic Measure: A Human-AI Collaborative Task

Published on: December 5, 2025

149

Related Experiment Videos

Last Updated: Jan 8, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.2K
Estimate the Cognitive Load Using Electrocardiographic Measure: A Human-AI Collaborative Task
07:08

Estimate the Cognitive Load Using Electrocardiographic Measure: A Human-AI Collaborative Task

Published on: December 5, 2025

149

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Deep Learning

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of death.
  • Primary care physicians are crucial for early CVD detection and prevention.
  • This study explores AI-driven cardiovascular risk (CVR) stratification in primary care.

Purpose of the Study:

  • Investigate the efficacy of AI-based temporal deep learning (DL) models for CVR stratification.
  • Support early detection and prevention of cardiovascular diseases in primary care settings.
  • Enhance patient management and resource allocation through AI integration.

Main Methods:

  • Implemented Long Short-Term Memory (LSTM) and Gated Recurrent Unit (GRU) temporal DL architectures.
  • Utilized a synthetic patient cohort with demographic and clinical data (age, sex, BMI, BP, smoking, diabetes, hypertension).
  • Trained models on sequential data to predict CVR categories and probabilities, benchmarking outputs against clinical recommendations.

Main Results:

  • LSTM and GRU models successfully forecasted CVR across various time horizons.
  • Model predictions were translated into clinically interpretable recommendations for follow-up and interventions.
  • Demonstrated the capability of temporal DL to predict cardiovascular risk with actionable insights.

Conclusions:

  • AI-driven CVR forecasting can enhance early intervention strategies in family medicine.
  • Optimized patient management and resource allocation are potential benefits of integrating AI.
  • Temporal DL shows promise for strengthening preventive care outcomes in primary care.